« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 14, Issue 12
, Pages
1380-1384
, December 2008
Treatment Change as a Predictor of Outcome among Patients with Classic Chronic Graft-versus-Host Disease
-
(A) Cumulative incidence of first change in treatment after initial systemic treatment for cGVHD. (B) Cumulative incidence of NRM after the initial diagnosis of cGVHD.
(A) Cumulative incidence of first change in treatment after initial systemic treatment for cGVHD. (B) Cumulative incidence of NRM after the initial diagnosis of cGVHD.
-
The cumulative incidence of NRM was higher for patients who had a treatment change within 4 months after initial systemic treatment for cGVHD (solid line) than for those who did not have a treatment c
The cumulative incidence of NRM was higher for patients who had a treatment change within 4 months after initial systemic treatment for cGVHD (solid line) than for those who did not have a treatment change during the first 4 months (dashed line).
Financial disclosure: See Acknowledgments on page 1383.
PII: S1083-8791(08)00416-3
doi: 10.1016/j.bbmt.2008.09.017
© 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 14, Issue 12
, Pages
1380-1384
, December 2008
